Frankfurt - Delayed Quote EUR

Ocular Therapeutix, Inc. (0OT.F)

Compare

7.41

-0.07

(-0.96%)

As of 8:43:02 AM GMT+1. Market Open.

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for 0OT.F

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR

Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation

Investors might be losing patience for Ocular Therapeutix's (NASDAQ:OCUL) increasing losses, as stock sheds 12% over the past week

Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Ocular Therapeutix announces over 300 subjects randomized in SOL-1

Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1

Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences

Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and ...

Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates

Ocular Therapeutix: Q3 Earnings Snapshot

2H51.BE Ocugen Inc

0.7285

+4.00%

2H51.MU Ocugen Inc

0.7490

+7.00%

2H51.DU Ocugen Inc

0.7355

+2.22%

ONC.TO Oncolytics Biotech Inc.

1.0600

+0.95%

CRDF Cardiff Oncology, Inc.

3.9700

+15.07%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Ocular Therapeutix, Inc. (0OT.F)

Comparisons

Indicators

Technicals

Corporate Events

0.19%

-7.05%

-28.56%

-3.06%